Paper Details
- Home
- Paper Details
HLA transgenic mice: application in reproducing idiosyncratic drug toxicity.
Author: AokiShigeki, ItoKousei, KuwaharaSaki, ShirayanagiTomohiro, SusukidaTakeshi, YamadaYushiro
Original Abstract of the Article :
Various types of transgenic mice carrying either class I or II human leukocyte antigen (HLA) molecules are readily available, and reports describing their use in a variety of studies have been published for more than 30 years. Examples of their use include the discovery of HLA-specific antigens agai...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1080/03602532.2020.1800725
データ提供:米国国立医学図書館(NLM)
HLA Transgenic Mice: A Powerful Tool for Unraveling Drug Toxicity
The realm of drug development is a vast desert, with many promising oases hidden within its sands. One of the most challenging aspects is predicting how drugs will interact with the human body. Sometimes, a drug that seems perfectly safe in preclinical studies can cause unexpected and severe reactions in humans. These are known as idiosyncratic drug toxicities (IDT), and they can be like a mirage – seemingly present but difficult to pinpoint.
This research explores a groundbreaking approach to understanding IDT by using HLA transgenic mice. These mice are genetically engineered to carry human HLA genes, which are crucial for immune system recognition. The study dives deep into the potential of these mice to mimic the complexities of human immune responses to drugs, potentially providing a more accurate way to predict IDT in humans.
They’ve found that HLA transgenic mice can successfully replicate IDT, even in cases like abacavir-induced IDT, which is notoriously difficult to predict. This is a major leap forward, as it allows scientists to investigate the underlying mechanisms of IDT in a controlled environment, paving the way for safer and more effective drug development.
The Potential of HLA Transgenic Mice
The ability to reproduce HLA-mediated IDT in mice is a significant breakthrough. The findings suggest that these models hold the potential to become an indispensable tool in drug development, allowing for the identification of potential IDT risks much earlier in the process. This could lead to a reduction in the number of drugs that fail in clinical trials due to unforeseen side effects.
The Future of Drug Safety
The use of HLA transgenic mice is a beacon of hope in the desert of drug development. By understanding the mechanisms of IDT, we can work towards a future where drugs are not only effective but also safer for everyone. This research is a reminder that even in the face of challenges, the pursuit of knowledge and innovation can lead to life-changing discoveries.
Dr.Camel's Conclusion
The use of HLA transgenic mice represents a major advance in our understanding of drug toxicity. By providing a more accurate way to predict IDT, these models have the potential to revolutionize drug development and make medications safer for everyone. It’s like finding a hidden oasis in the desert, providing a vital source of knowledge and hope for a healthier future.
Date :
- Date Completed 2021-09-07
- Date Revised 2021-09-07
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.